Evidence mapPaperPMID 40343103Full record

SynthesisFrontiers in psychiatry2025

Suicidal risk in patients with aggression in schizophrenia: a systematic review.

Lidia Bravve, Maria Kaydan, Georgy Kostyuk

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The effect of impoverishment of thought in early psychosis: Influence on suicide risk via depression and aggression.Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lidia Bravve *Scientific and Clinical Research Centre for Neuropsychiatry of "Psychiatric Hospital no. 1 Named after N.A. Alexeev of the Department of Health of Moscow, Moscow, Russia.
Maria Kaydan *Scientific and Clinical Research Centre for Neuropsychiatry of "Psychiatric Hospital no. 1 Named after N.A. Alexeev of the Department of Health of Moscow, Moscow, Russia.
Georgy Kostyuk *Scientific and Clinical Research Centre for Neuropsychiatry of "Psychiatric Hospital no. 1 Named after N.A. Alexeev of the Department of Health of Moscow, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Suicide represents the primary risk factor for mortality among individuals diagnosed with schizophrenia, with a mortality rate that is 10 times higher than that observed in the general population. In the study of individuals who have committed suicide, some exhibited a high risk of aggression and impulsivity, which permitted the consideration of these indicators as predictors of suicide risk. The extant literature contains a number of debates concerning diverse conceptualizations of aggression and impulsivity in the context of suicidal behavior. The present study examined the levels of verbal and physical aggression in individuals diagnosed with schizophrenia, finding that 43% exhibited verbal aggression and 24% physical aggression, levels that are significantly higher than those observed in the general population. Concurrently, an analysis of the psycho-emotional state of patients with suicidal behavior in the anamnesis reveals an indication that the suppression of emotions (including aggression) and the avoidance of harm may result in suicide. This finding is at odds with the previously mentioned results, and consequently, the present review sought to assess the impact of aggressive behavior on suicide risk in patients diagnosed with schizophrenia. Methods: The search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The literature search was conducted in PubMed, Cochrane Library, PsychINFO and Mendeley Data. The search terms used were "aggress*" and "suicid*" or "autoaggress*" and "schizophrenia*". The search was limited to papers published between 2009 and 2024 (the last 15 years), and the search was continued until November 2024. This systematic review has been registered in PROSPERO (CRD42024628033). Results: A total of 1,364 articles were identified, 295 of which were duplicates. Following a thorough review, 1,046 articles that did not align with the title and abstract were excluded from the analysis. During the literature search, 23 articles were read in full, of which eight studies met the inclusion criteria. A total of eight studies provided information on the effect of aggressive behavior on suicide in patients with schizophrenia. Of these, six studies demonstrated a positive association between aggression and suicidal behavior or employed a logistic regression model in which the risk of aggression increased the risk of suicide and vice versa. Conversely, two studies revealed no association between suicide risk and aggression. Conclusions: Patients with a documented history of suicide attempts and aggressive behavior are considered to be at risk of suicide, thus emphasizing the necessity for preventive measures to be implemented for this cohort of patients. However, the conclusion regarding the influence of aggressive behavior on increased suicide risk may not be entirely accurate and may not reflect the true extent of the problem, due to the significant number of methodological inaccuracies and discrepancies in the design of the studies included in the review. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024628033, identifier CRD42024628033.

Indexed as

aggressionaggressive behaviorschizophreniasuicidesuicide risk

Identifiers

PMID40343103
PMCPMC12058775

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.